logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Nature Reviews Drug Discovery cover

Nature Reviews Drug Discovery

IF101.8
Papers5135
Citations52850
Journal Papers 5714
Publication Date
delete
Psychedelic protects against chemotherapy-induced nerve damage
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-29
delete0
PREAI
deleteKatie Kingwell
deleteShare
deleteSave
Drug conjugate allows cell surface payload release
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-28
delete0
PREAI
deleteAlex Eccleston
deleteShare
deleteSave
From N-of-1 therapy to health-system implementation
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-25
delete0
PREAI
deleteHaiyan Zhou; Alice E. Davidson; Mina Ryten; Ella F. Whittle; Catherine Ryan; Nick Lench; Daniel J. O’Connor; Carlo Rinaldi; Francesco Muntoni
deleteShare
deleteSave
Refining therapeutic targeting of interleukin-6 by signalling mode selectivity
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-23
delete0
PREAI
deleteStefan Rose-John; Georg H. Waetzig; Stefan Schreiber
deleteShare
deleteSave
Navigating ultralarge virtual screening
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-22
delete0
PREAI
deleteSarah Crunkhorn
deleteShare
deleteSave
Suppressor tRNA rescues cystic fibrosis
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-22
delete0
PREAI
deleteSarah Crunkhorn
deleteShare
deleteSave
Targeting norovirus RNA structures
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-22
delete0
PREAI
deleteSarah Crunkhorn
deleteShare
deleteSave
Covalent BAX inhibitor confers cytoprotection
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-22
delete0
PREAI
deleteSarah Crunkhorn
deleteShare
deleteSave
Two trials or not two trials? That should not be the question
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-21
delete0
PREAI
deletePeter Arlett; Steffen Thirstrup; Francesca Day; Juan Garcia Burgos; Nacho Mbaeliachi; Paolo Foggi; Kit Roes; Emer Cooke; Bruno Sepodes
deleteShare
deleteSave
The evolving landscape of drug targets
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-21
delete0
PREAI
deleteLiliana Halip; Sorin Avram; John P. Overington; Bissan Al-Lazikani; Ramona Curpan; Suman Sirimulla; Alexei Pushechnikov; Andrea Rosario Beccari; Nikolay Savchuck; Tudor I. Oprea
deleteShare
deleteSave
The value of speed for drug developers
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-18
delete0
PREAI
deleteDavid B. Ridley; Chenxi Xu
deleteShare
deleteSave
First myostatin-targeted antibody approved for spinal muscular atrophy
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-18
delete0
PREAI
deleteAsher Mullard
deleteShare
deleteSave
Selective oestrogen receptor degrader class grows with new cancer approval
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-11
delete0
PREAI
deleteAsher Mullard
deleteShare
deleteSave
Upcoming FDA approval decisions in Q4 2026
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-09
delete0
PREAI
deleteKaniaw Dilzer
deleteShare
deleteSave
A translational framework for extrahepatic oligonucleotide delivery
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-09
delete0
PREAI
deleteŁukasz Jan Kiełpiński; Felix Franz Schumacher
deleteShare
deleteSave
Un-siloed biomedical opportunities
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-07
delete0
PREAI
deleteAsher Mullard
deleteShare
deleteSave
Strengthening muscle for healthy ageing: innovative treatments for sarcopenia
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-07
delete0
PREAI
deleteSara Ancel; Emmeran Le Moal; Yu Xin Wang; Helen M. Blau
deleteShare
deleteSave
Newest glue degrader nabs multiple myeloma approval
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-04
delete0
PREAI
deleteAsher Mullard
deleteShare
deleteSave
Click chemistry platform enhances ADC tumour targeting
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-02
delete0
PREAI
deleteAlex Eccleston
deleteShare
deleteSave
Solute carrier membrane transporters: emerging targets in CNS disorders
deleteNature Reviews Drug Discovery
IF101.8
delete2026-09-01
delete0
PREAI
deleteYee Kwan Law; Selene Glück; Enrico Girardi; Ariel Bensimon; S. Andreas Angermayr; Giulio Superti-Furga
deleteShare
deleteSave